John R. Brumsted — Endo Lab

article 1997

P-168 Abnormal ovulation in women with endometriosis

·doi:10.1016/s0015-0282(97)90983-3

article 1996

The association of intrauterine filling defects on hysterosalpingogram with endometriosis

Fertility and sterility ·doi:10.1016/s0015-0282(16)58562-8

ObjectiveTo determine whether there is a significant association between the presence of polyps or polypoid endometrium on hysterosalpingogram (HSG) with the presence of pelvic or peritoneal endometriosis.DesignRetrospective chart review.Se…

article 1995

Color flow pulsed Doppler ultrasound in diagnosing luteal phase defect

·doi:10.1016/s0015-0282(16)57783-8

ObjectiveTo determine whether color flow pulsed Doppler analysis of corpus luteum blood flow in normal cycles differs from cycles with a luteal phase defect.DesignA prospective study of natural ovarian cycles.SettingThe University of Vermon…

article 1993

In Vitro CA-125 Secretion by Endometrium From Women With Advanced Endometriosis

·doi:10.1097/00006254-199306000-00020

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, Vermont

article 1990

A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis

·doi:10.1016/s0015-0282(16)54009-6

This study was initiated to test the hypothesis that treatment with clomiphene citrate (CC) and intrauterine insemination (IUI) results in increased fecundity when compared with periovulatory intercourse in couples with either unexplained i…

article 1989

Prostaglandin F2 synthesis and metabolism by luteal phase endometrium in vitro

·doi:10.1016/s0015-0282(16)61029-4

Differences in prostaglandin (PG) F2 alpha synthesis and degradation were sought between early luteal endometrium (histology day 15 to 22, n = 6) and late luteal endometrium (histology day 23 to 28, n = 6). In addition, alterations in PGF2 …

article 1988

Reproductive outcome after medical management of complicated pelvic inflammatory disease

·doi:10.1016/s0015-0282(16)60206-6

A significant proportion of women with PID will have their disease complicated by a TOC. We conclude that it is appropriate in women with this stage of PID to treat initially with clindamycin and an aminoglycoside. In addition, since more t…